Revvity establishes In Vivo Imaging Center of Excellence in North Carolina
Facility designed to advance the next generation of imaging systems
Facility designed to advance the next generation of imaging systems
Accelerated platform delivers validated biomarkers with ready-to-use Optimer ligands in months rather than years
Collaboration leverages advanced simulation and regulatory expertise to develop decision frameworks for interim overall survival analysis in oncology clinical trials
New range of StarBright™ Dyes developed specifically for spectral flow cytometry provide greater flexibility in immunology research
CAL101 is a first-in-class monoclonal antibody that neutralises the S100A4 protein, which is an upstream driver and amplifier of the multiple pro-fibrotic pathways active in IPF
The MosaiQ instrument is a next-generation, continuous random-access immunoassay platform offering labs automation, simple workflows, fast, multiplexed results and actionable insights for complex-to-diagnose conditions
As cell line development programs for biopharmaceutical development grow in complexity and scale, with increasing demands for speed, data quality, and adaptability, it is essential to choose the right analytical technology and tools that will future proof your workflow.